It is given as a once-weekly injection under the skin and is used to help manage type 2 diabetes
Rybelsus is only licensed for type 2 diabetes in the UK and should not be prescribed for weight loss alone
Begin treatment with home delivery and continued support via the care team, ensuring comfort and confidence throughout your journey
Multisite research, including research at UAB, shows that oral semaglutide is nearly as effective as the widely used injectable version for treating obesity, delivering about 13.7 percent average weight loss over 64 weeks
Real-world cardiovascular benefits are linked to weight loss, improved blood pressure, and reduced inflammation, Ali notes
Legal rights vary by state, and filing deadlines are strict